The Market Quotes Powered By Forexpros, the Forex, Futures, and Stock Markets Portal.
Astepro approved in EuropeTuesday, 20 March 2012
Astepro has received registration approval in Europe via the decentralized procedure. Astepro is a new nasal spray for the treatment of allergic rhinitis. National registration processes, including price and reimbursement, will now follow in each country. Launch is expected next year.
"We are pleased to announce the approval of Astepro in Europe. The product has been launched in the US with good success. With the addition of Dymista (currently in registration phase) Meda will have an extraordinary strong position in the allergy rhinitis area, both in the US and Europe", said Anders Lönner, CEO of Meda AB.
What do you think about this article or us? Please leave a comment. Thank you!